Adalimumab added to Methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, DMARD-naïve patients with rheumatoid arthritis - An investigator-initiated randomized, controlled, double-blinded study.
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Adalimumab added to Methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, DMARD-naïve patients with rheumatoid arthritis - An investigator-initiated randomized, controlled, double-blinded study.
| Original language | English |
|---|---|
| Journal | Arthritis & Rheumatism |
| Volume | 63 |
| Issue number | 10 (suppl.) |
| Pages (from-to) | S147 |
| Number of pages | 1 |
| ISSN | 0004-3591 |
| Publication status | Published - 2011 |
ID: 40159956